Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Evans

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|December 24, 2005
Inhaled nitric oxide therapy in adultsMark J D Griffiths, Timothy W Evans
Critical Care (London, England)|May 22, 2008
The promise of next generation colloidsBen C Creagh-Brown, Timothy W Evans
Current Opinion in Critical Care|September 3, 2002
Pulmonary versus extrapulmonary acute respiratory distress syndrome: different diseases or just a useful concept?Matthew E J Callister, Timothy W Evans
Critical Care (London, England)|May 10, 2008
Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter?Hongmei Gao, Timothy W Evans, Simon J Finney
European Journal of Pharmacology|August 9, 2002
Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shockSusanna Price, Timothy W Evans, Jane A Mitchell
Clinical Science (London, England : 1979)|April 16, 2005
Redox regulation of neutrophil apoptosis and the systemic inflammatory response syndromeDaniel D Melley, Timothy W Evans, Gregory J Quinlan
Intensive Care Medicine|June 16, 2009
Haem oxygenase-1 polymorphism and ARDS, friend and foe?Anna L Lagan, Gregory J Quinlan, Timothy W Evans
Hepatology (Baltimore, Md.)|May 26, 2005
Albumin: biochemical properties and therapeutic potentialGregory J Quinlan, Greg S Martin, Timothy W Evans
Critical Care Medicine|June 19, 2009
Thioredoxin in sepsis: Just another biomarker or a plausible therapeutic target?Anne Burke-Gaffney, Timothy W Evans, Gregory J Quinlan
Intensive Care Medicine|February 21, 2008
Haem oxygenase: a model for therapeutic interventionGregory J Quinlan, Anna L Lagan, Timothy W Evans
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|December 24, 2005
Inhaled nitric oxide therapy in adultsMark J D Griffiths, Timothy W Evans
Critical Care (London, England)|May 22, 2008
The promise of next generation colloidsBen C Creagh-Brown, Timothy W Evans
Current Opinion in Critical Care|September 3, 2002
Pulmonary versus extrapulmonary acute respiratory distress syndrome: different diseases or just a useful concept?Matthew E J Callister, Timothy W Evans
Critical Care (London, England)|May 10, 2008
Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter?Hongmei Gao, Timothy W Evans, Simon J Finney
European Journal of Pharmacology|August 9, 2002
Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shockSusanna Price, Timothy W Evans, Jane A Mitchell
Clinical Science (London, England : 1979)|April 16, 2005
Redox regulation of neutrophil apoptosis and the systemic inflammatory response syndromeDaniel D Melley, Timothy W Evans, Gregory J Quinlan
Intensive Care Medicine|June 16, 2009
Haem oxygenase-1 polymorphism and ARDS, friend and foe?Anna L Lagan, Gregory J Quinlan, Timothy W Evans
Hepatology (Baltimore, Md.)|May 26, 2005
Albumin: biochemical properties and therapeutic potentialGregory J Quinlan, Greg S Martin, Timothy W Evans
Critical Care Medicine|June 19, 2009
Thioredoxin in sepsis: Just another biomarker or a plausible therapeutic target?Anne Burke-Gaffney, Timothy W Evans, Gregory J Quinlan
Intensive Care Medicine|February 21, 2008
Haem oxygenase: a model for therapeutic interventionGregory J Quinlan, Anna L Lagan, Timothy W Evans
Pageof 7